<unk>  (NS2330) is a serotonin–noradrenaline–dopamine reuptake inhibitor from the phenyltropane family of drugs, which is being developed for the treatment of obesity.<unk>  was originally developed by a Danish biotechnology company, NeuroSearch, who transferred the rights to Saniona in 2014. As of 2019,<unk>  has been discontinued for the treatment of Alzheimer's and Parkinson's disease but is in phase III clinical trial for obesity.
Tesofensine
Ephedrine
Pseudoephedrine
Guaifenesin
Benzoctamine
Bethanechol
Clofoctol
Glycopyrronium bromide